Edition:
United Kingdom

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

75.42USD
17 Jan 2018
Change (% chg)

-- (--)
Prev Close
$75.42
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
183,824
52-wk High
$92.00
52-wk Low
$31.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 5.89 -0.862
Mar '17 5.84 -0.843
FY 2016 Dec '16 7.69 -0.747
Sep '16 6.16 -0.618
Jun '16 7.07 -0.695
Mar '16 6.86 -0.572
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 7 4.49 7.00 1.12 --
Quarter Ending Jun-18 7 4.53 7.25 1.12 --
Year Ending Dec-18 9 13.88 29.40 1.70 14.49
Earnings (per share)
Quarter Ending Mar-18 7 -1.10 -0.87 -1.27 --
Quarter Ending Jun-18 7 -1.13 -0.91 -1.30 --
Year Ending Dec-18 9 -4.70 -3.69 -5.68 -4.67
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.75 32.90
P/E High - Last 5 Yrs. -- 302.25 46.03
P/E Low - Last 5 Yrs. -- 94.23 24.39
Beta -- 0.88 0.89
Price to Sales (TTM) 101.33 94.46 5.41
Price to Book (MRQ) 6.92 13.37 5.38
Price to Tangible Book (MRQ) 6.93 13.65 6.89
Price to Cash Flow (TTM) -- 72.91 23.43
% Owned Institutions -- 11.52 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.51
Dividend 5 Year Growth Rate -- 1.72 5.23
Payout Ratio(TTM) -- 16.23 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -16.63 401.35 9.01
Sales (TTM) vs TTM 1 Yr. Ago 16.37 70.94 5.44
Sales - 5 Yr. Growth Rate -- 33.11 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.91 29.52 19.33
EPS (TTM) vs TTM 1 Yr. Ago -32.61 -- --
EPS - 5 Yr. Growth Rate -- 40.23 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.36 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 13.07 5.22 2.97
LT Debt to Equity (MRQ) 0.18 21.07 12.10
Total Debt to Equity (MRQ) 0.71 22.62 16.38
Interest Coverage (TTM) -103.52 -102.11 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.23 54.86
Gross Margin - 5 Yr. Avg. -- 52.57 52.45
EBITD Margin (TTM) -387.82 -- --
EBITD - 5 Yr. Avg -- -239.65 15.33
Operating Margin (TTM) -394.04 -519.48 7.74
Operating Margin - 5 Yr. Avg. -- -256.84 10.79
Pre-Tax Margin (TTM) -388.91 -495.13 8.53
Pre-Tax Margin - 5 Yr. Avg. -- -256.77 11.19
Net Profit Margin (TTM) -388.91 -496.63 4.84
Net Profit Margin - 5 Yr. Avg. -- -259.99 7.50
Effective Tax Rate (TTM) -- 23.31 23.05
Effective Tax Rate - 5 Yr. Avg. -- 18.78 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 241,330 23,331,032 855,738,258
Net Income/Employee (TTM) -938,547 3,081,067 100,666,768
Receivable Turnover (TTM) 7.96 20.25 5.76
Inventory Turnover (TTM) -- 2.31 3.34
Asset Turnover (TTM) 0.08 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.52 0.10 10.97
Return on Assets - 5 Yr. Avg. -- 0.51 12.39
Return on Investment (TTM) -34.88 3.21 14.40
Return on Investment - 5 Yr. Avg. -- 3.64 16.20
Return on Equity (TTM) -40.89 4.54 16.09
Return on Equity - 5 Yr. Avg. -- 8.99 17.53
  1 Year 3 Year 5 Year
Sales % 143.61 -- --
EPS (TTM) % 14.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Blueprint Medicines Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 26.74 22.37 88 48
13 Week 24.13 18.08 80 60
26 Week 48.03 36.78 85 70
52 Week 147.42 109.71 92 47
YTD 136.22 107.45 92 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 92.73%
# of Holders: 208
Total Shares Held: 39,766,179
3 Mo. Net Change: 45,544
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 15
# Reduced Positions: 5
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.